Programs

As a private-sector research enterprise, Canadian Health Policy Institute (CHPI) hosts topically focused research programs, chaired by CHPI affiliated scholars and sponsored by non-government sources. Active programs are shown below.

Access to Innovative Medicines

RESEARCH CHAIR: Brett J Skinner, Ph.D.

This research program is focused on evidence-based analysis of policy issues related to access to innovative medicines for Canadians. The program is partially funded by sponsors including:

Subscribe image

CHP blogazine

National pharmacare advisory council’s report leaves many unanswered questions.

By Nigel SB Rawson, Ph.D. The 2019 federal budget announced that the government will take »

Opinions

New rules will keep the best medications from desperate Canadians

Nigel S. B. Rawson and John Adams | Financial Post | September 12, 2019 »
Proposed new drug regulations will hurt all Canadians.

Nigel Rawson | Financial Post | August 13, 2019 »
Don't blow up pharmacare as we know it. Just fill the gaps.

Brett Skinner | Financial Post | June 25, 2019 »

News

Health Canada requires hospitals to report adverse drug reactions and medical device incidents.

Health Canada recently announced new regulations t »
CADTH and BC Pharmacare move to ease entry of biosimilar drugs.

The Canadian Agency for Drugs and Technologies in »
Council on the Implementation of National Pharmacare releases final report.

The federal Council on the Implementation of Natio »

Copyright © 2019 Canadian Health Policy Institute (CHPI)
•
XML Sitemap
•
Valid XHTML